Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EIGR
5326
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $166K | ﹤0.01% |
504
-19
| -4% | -$5.18K |
2014 Q4
11 quarters
|
|
|
SOIL
5327
DELISTED
Global X Fertilizers/Potash ETF
SOIL
| $165K | ﹤0.01% |
16,277
+14,035
| +626% | +$136K |
2013 Q2
17 quarters
|
|
|
FONE
5328
DELISTED
First Trust NASDAQ Smartphone Index Fund
FONE
| $165K | ﹤0.01% |
3,300
+150
| +5% | +$7.39K |
2017 Q1
2 quarters
|
|
|
FMK
5329
DELISTED
First Trust Mega Cap AlphaDEX Fund
FMK
| $164K | ﹤0.01% |
5,148
+235
| +5% | +$7.26K |
2013 Q4
15 quarters
|
|
|
SPYB
5330
DELISTED
SPDR S&P 500 Buyback ETF
SPYB
| $164K | ﹤0.01% |
2,825
-185
| -6% | -$10.4K |
2015 Q2
9 quarters
|
|
|
BBRG
5331
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $164K | ﹤0.01% |
72,194
-86,830
| -55% | -$272K |
2013 Q2
17 quarters
|
|
5332
The9 Ltd
NCTY
$51.8M
| $163K | ﹤0.01% |
567
+8
| +1% | +$2.48K |
2014 Q1
14 quarters
|
|
5333
Viridian Therapeutics
VRDN
$2.22B
| $163K | ﹤0.01% |
1,185
+413
| +53% | +$69.5K |
2017 Q1
2 quarters
|
|
|
BYBK
5334
DELISTED
Bay Bancorp, Inc.
BYBK
| $163K | ﹤0.01% |
14,409
-695
| -5% | -$5.51K |
2013 Q4
15 quarters
|
|
|
OMED
5335
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $163K | ﹤0.01% |
36,055
+7,476
| +26% | +$30.3K |
2013 Q3
16 quarters
|
|
5336
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.56B
| $162K | ﹤0.01% |
7,231
-1,334
| -16% | -$29.3K |
2016 Q4
3 quarters
|
|
5337
Source Capital
SOR
$372M
| $162K | ﹤0.01% |
4,033
+168
| +4% | +$6.61K |
2013 Q2
17 quarters
|
|
5338
Direxion Daily FTSE China Bear 3X ETF
YANG
$95.8M
| $162K | ﹤0.01% |
107
+101
| +1,683% | +$169K |
2013 Q4
15 quarters
|
|
5339
NXG NextGen Infrastructure Income Fund
NXG
$405M
| $161K | ﹤0.01% |
2,161
-16,128
| -88% | -$1.13M |
2013 Q2
17 quarters
|
|
5340
VolitionRx Ltd
VNRX
$5.67M
| $161K | ﹤0.01% |
3,070
+125
| +4% | +$7.34K |
2015 Q1
10 quarters
|
|
|
AST
5341
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $160K | ﹤0.01% |
47,182
+7,963
| +20% | +$26.8K |
2014 Q4
11 quarters
|
|
5342
Aptevo Therapeutics
APVO
$3.08M
| – | – |
0
| – | – |
2016 Q3
4 quarters
|
|
|
HYLV
5343
DELISTED
IQ S&P High Yield Low Volatility Bond ETF
HYLV
| $159K | ﹤0.01% |
6,236
+100
| +2% | +$2.54K |
2017 Q2
1 quarter
|
|
|
PZE
5344
DELISTED
Petrobras Argentina S A
PZE
| $159K | ﹤0.01% |
12,594
-1,445
| -10% | -$17K |
2013 Q4
15 quarters
|
|
|
EVOL
5345
DELISTED
Evolving Systems, Inc.
EVOL
| $159K | ﹤0.01% |
32,835
-1,666
| -5% | -$8.04K |
2013 Q2
17 quarters
|
|
5346
DELISTED
United Security Bancshares
UBFO
| $158K | ﹤0.01% |
16,602
+4,530
| +38% | +$42.5K |
2017 Q1
2 quarters
|
|
|
ROX
5347
DELISTED
Castle Brands, Inc.
ROX
| $158K | ﹤0.01% |
117,559
+35,916
| +44% | +$57.3K |
2017 Q1
2 quarters
|
|
|
DRK
5348
DarkHorse Technologies Inc. Common Shares
DRK
$22.9M
| $157K | ﹤0.01% |
127
+37
| +41% | +$85.6K |
2016 Q4
3 quarters
|
|
5349
iShares MSCI Norway ETF
ENOR
$228M
| $157K | ﹤0.01% |
6,043
+4,154
| +220% | +$102K |
2016 Q3
4 quarters
|
|
5350
Mizuho Financial
MFG
$123B
| $157K | ﹤0.01% |
44,270
+2,789
| +7% | +$9.8K |
2013 Q3
16 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.